Jiankang Chen

Medicine & Life Sciences

1. 14,15-epoxy-5,8,11-eicosatrienoic acid 58%
2. 2-(14,15-epoxyeicosatrienoyl)glycerol 26%
3. Acids 16%
4. Acute Kidney Injury 27%
5. Angiotensin II 31%
6. Angiotensin Type 1 Receptor 11%
7. AP301 peptide 15%
8. Apoptosis 20%
9. arachidonate epoxygenase 38%
10. Arachidonic Acid 19%
11. Autophagy 40%
12. Caveolins 10%
13. Cisplatin 13%
14. Class III Phosphatidylinositol 3-Kinases 14%
15. CSK Tyrosine-Protein Kinase 10%
16. Cytochrome P-450 Enzyme System 31%
17. des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 12%
18. Diabetic Nephropathies 19%
19. Epidermal Growth Factor 19%
20. Epithelial Cells 35%
21. ErbB Receptors 53%
22. Extracellular Signal-Regulated MAP Kinases 10%
23. Fibrosis 21%
24. Growth 15%
25. Heparin-binding EGF-like Growth Factor 19%
26. Hypertrophy 42%
27. Inbred Dahl Rats 10%
28. Insulin 10%
29. interferon regulatory factor-8 12%
30. Kidney 100%
31. Knockout Mice 15%
32. Lenses 13%
33. Mechanistic Target of Rapamycin Complex 1 12%
34. Nephrons 22%
35. Paxillin 10%
36. Phosphatidylinositol 3-Kinase 10%
37. Phosphatidylinositol 3-Kinases 12%
38. Phosphorylation 50%
39. Podocytes 54%
40. Protein-Tyrosine Kinases 12%
41. Proximal Kidney Tubule 46%
42. Re-Epithelialization 9%
43. Reperfusion 12%
44. Ribosomal Protein S6 42%
45. Ribosomal Protein S6 Kinases 13%
46. TOR Serine-Threonine Kinases 19%
47. Tuberous Sclerosis Complex 1 Protein 12%
48. Tyrosine 24%
49. Up-Regulation 11%
50. Wounds and Injuries 30%